Abstract
Reduced membranous expression of the cytoskeleton-associated protein ezrin has previously been demonstrated to correlate with poor prognosis in urothelial bladder cancer in several independent studies. The present study provides a first description of clinicopathological characteristics of incident urothelial cancers, not only located to the bladder, in the prospective, population-based cohort study Malmö Diet and Cancer. In addition, the prognostic value of ezrin expression is validated in primary tumours, and the longitudinal expression of ezrin examined in a subset of primary and recurrent tumours (n = 28).
Original language | English |
---|---|
Article number | 189 |
Journal | Diagnostic Pathology |
Volume | 9 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2014 |
Bibliographical note
The information about affiliations in this record was updated in December 2015.The record was previously connected to the following departments: Pathology, (Lund) (013030000)
Subject classification (UKÄ)
- Cancer and Oncology